Side effects of long-term treatment with chloroquine for rheumatoid arthritis - a review of the literature
DOI:
https://doi.org/10.12775/JEHS.2023.13.02.023Keywords
Chloroquin, Chloroquin rheumatoid, Chloroquin toxicity, Chloroquine, Chloroquine rheumatoid, Chloroquine toxicityAbstract
Background: Chloroquine is a 4-aminoquinoline derivative. Initially the substance was used as an antimalarial drug, but now chloroquine is also used to treat connective tissue diseases. It is a widely used drug in rheumatological diseases, especially in rheumatoid arthritis and systemic lupus erythematosus. A number of side effects have been reported in the public literature among patients using this drug. This article reviews side effects during long-term treatment of patients with rheumatoid arthritis.
Materials and methods: A review of the literature available in the PubMed database was performed, using the key words: "Chloroquin" ; "Chloroquin rheumatoid" ; "Chloroquin toxicity" ; "Chloroquine" ; "Chloroquine rheumatoid" ; "Chloroquine toxicity".
Results: Chloroquine is a quinine derivative, originally used in the prevention and treatment of malaria. It is now being successfully used to treat patients with certain connective tissue diseases, including rheumatoid arthritis. A number of publications have described various side effects of this drug. Serious and major problems arise from the drug's toxicity with long-term use, such as in the treatment of rheumatoid arthritis. Long-term use of the drug results in retinopathy and cardiotoxicity (conduction disturbances, cardiomyopathy). The available literature also mentions neuromyotoxicity which is rarely reported by patients.
Conclusion: Long-term use of chloroquine carries serious side effects. The main complications of long-term use of the drug affect the visual, cardiovascular and nervous systems. The use of chloroquine in patients with rheumatoid arthritis should emphasize the need for accurate dosing and periodic cardiovascular, ophthalmologic and neurologic monitoring.
References
Chlorochina (chloroquine). indeks.mp.pl [indeks.mp.pl/leki/desc.php?id=165] (polish).
Nirk EL, Reggiori F, Mauthe M. Hydroxychloroquine in rheumatic autoimmune disorders and beyond. EMBO Mol Med. 2020 Aug 7;12(8):e12476. doi: 10.15252/emmm.202012476. Epub 2020 Jul 26. PMID: 32715647; PMCID: PMC7411564.
Doyno C, Sobieraj DM, Baker WL. Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. Clin Toxicol (Phila). 2021 Jan;59(1):12-23. doi: 10.1080/15563650.2020.1817479. Epub 2020 Sep 22. PMID: 32960100.
Olansky AJ. Antimalarials and ophthalmologic safety. J Am Acad Dermatol. 1982 Jan;6(1):19-23. doi: 10.1016/s0190-9622(82)70002-7. PMID: 7045172.
Aylward JM. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity. J Am Optom Assoc. 1993 Nov;64(11):787-97. PMID: 8120333.
Costedoat-Chalumeau N, Dunogué B, Leroux G, Morel N, Jallouli M, Le Guern V, Piette JC, Brézin AP, Melles RB, Marmor MF. A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye. Clin Rev Allergy Immunol. 2015 Dec;49(3):317-26. doi: 10.1007/s12016-015-8469-8. PMID: 25672591.
Ferreras A, Pinilla I, Abecia E, Pajarín AB, Honrubia FM. Toxicidad retiniana secundaria a tratamiento con cloroquina [Retinal toxicity following chloroquine therapy]. Arch Soc Esp Oftalmol. 2007 Feb;82(2):103-8. Spanish. doi: 10.4321/s0365-66912007000200008. PMID: 17323250.
Lacava AC. Complicações oculares da terapêutica com a cloroquina e derivados [Ocular complications of chloroquine and derivatives therapy]. Arq Bras Oftalmol. 2010 Jul-Aug;73(4):384-9. Portuguese. doi: 10.1590/s0004-27492010000400019. PMID: 20944948.
Michaelides M, Stover NB, Francis PJ, Weleber RG. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Arch Ophthalmol. 2011 Jan;129(1):30-9. doi: 10.1001/archophthalmol.2010.321. PMID: 21220626.
Wiacek MP, Bobrowska-Snarska D, Lubiński W, Brzosko M, Modrzejewska M. What is new in recommendations on ophthalmological screening in patients treated with chloroquine and hydroxychloroquine? Update and literature review. Niger J Clin Pract. 2017 Aug;20(8):919-923. doi: 10.4103/njcp.njcp_380_16. PMID: 28891533.
Puavilai S, Kunavisarut S, Vatanasuk M, Timpatanapong P, Sriwong ST, Janwitayanujit S, Nantiruj K, Totemchokchyakarn K, Ruangkanchanasetr S. Ocular toxicity of chloroquine among Thai patients. Int J Dermatol. 1999 Dec;38(12):934-7. doi: 10.1046/j.1365-4362.1999.00849.x. PMID: 10632778.
Finbloom DS, Silver K, Newsome DA, Gunkel R. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J Rheumatol. 1985 Aug;12(4):692-4. PMID: 4057189.
Elman A, Gullberg R, Nilsson E, Rendahl I, Wachtmeister L. Chloroquine retinopathy in patients with rheumatoid arthritis. Scand J Rheumatol. 1976;5(3):161-66. doi: 10.3109/03009747609165456. PMID: 981992.
Li X, Fei J, Lei Z, Liu K, Wu J, Meng T, Yu J, Li J. Chloroquine impairs visual transduction via modulation of acid sensing ion channel 1a. Toxicol Lett. 2014 Aug 4;228(3):200-6. doi: 10.1016/j.toxlet.2014.05.008. Epub 2014 May 10. PMID: 24821433.
Lai WW, Lam DS. Chloroquine-induced bull's eye maculopathy. Hong Kong Med J. 2005 Feb;11(1):55-7. PMID: 15687518.
Schroeder RL, Pendleton P, Gerber JP. Physical factors affecting chloroquine binding to melanin. Colloids Surf B Biointerfaces. 2015 Oct 1;134:8-16. doi: 10.1016/j.colsurfb.2015.06.040. Epub 2015 Jun 25. PMID: 26141438.
Percival SP, Meanock I. Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis. Br Med J. 1968 Sep 7;3(5618):579-84. doi: 10.1136/bmj.3.5618.579. PMID: 4875645; PMCID: PMC1991130.
Leecharoen S, Wangkaew S, Louthrenoo W. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma. J Med Assoc Thai. 2007 Jan;90(1):52-8. PMID: 17621733.
Ingster-Moati I, Bui Quoc E, Crochet M, Orssaud C, Dufier JL, Roche O. Intoxication rétinienne sévère aux anti-paludéens de synthèse [Severe chloroquine- and hydroxychloroquine-induced retinopathy]. J Fr Ophtalmol. 2006 Jun;29(6):642-50. French. doi: 10.1016/s0181-5512(06)73825-6. PMID: 16885894.
Chiowchanwisawakit P, Nilganuwong S, Srinonprasert V, Boonprasert R, Chandranipapongse W, Chatsiricharoenkul S, Katchamart W, Pongnarin P, Danwiriyakul W, Koolvisoot A, Arromdee E, Ruangvaravate N. Prevalence and risk factors for chloroquine maculopathy and role of plasma chloroquine and desethylchloroquine concentrations in predicting chloroquine maculopathy. Int J Rheum Dis. 2013 Feb;16(1):47-55. doi: 10.1111/1756-185X.12029. Epub 2013 Jan 18. PMID: 23441772.
LLOYD LA, HILTZ JW. OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY. Can Med Assoc J. 1965 Mar 6;92(10):508-13. PMID: 14275038; PMCID: PMC1928171.
Bonanomi MT, Dantas NC, Medeiros FA. Retinal nerve fibre layer thickness measurements in patients using chloroquine. Clin Exp Ophthalmol. 2006 Mar;34(2):130-6. doi: 10.1111/j.1442-9071.2006.01167.x. PMID: 16626426.
Ehrenfeld M, Nesher R, Merin S. Delayed-onset chloroquine retinopathy. Br J Ophthalmol. 1986 Apr;70(4):281-3. doi: 10.1136/bjo.70.4.281. PMID: 3964626; PMCID: PMC1040997.
Xiaoyun MA, Dongyi HE, Linping HE. Assessing chloroquine toxicity in RA patients using retinal nerve fibre layer thickness, multifocal electroretinography and visual field test. Br J Ophthalmol. 2010 Dec;94(12):1632-6. doi: 10.1136/bjo.2009.171082. Epub 2010 Oct 8. PMID: 20935309.
Browning DJ. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity. Am J Ophthalmol. 2002 May;133(5):649-56. doi: 10.1016/s0002-9394(02)01392-2. PMID: 11992862.
Marks JS. Chloroquine retinopathy: is there a safe daily dose? Ann Rheum Dis. 1982 Feb;41(1):52-8. doi: 10.1136/ard.41.1.52. PMID: 7065730; PMCID: PMC1000864.
Della Porta A, Bornstein K, Coye A, Montrief T, Long B, Parris MA. Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians. Am J Emerg Med. 2020 Oct;38(10):2209-2217. doi: 10.1016/j.ajem.2020.07.030. Epub 2020 Jul 19. PMID: 33071096; PMCID: PMC7369162.
Jordaan P, Dumotier B, Traebert M, Miller PE, Ghetti A, Urban L, Abi-Gerges N. Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes. Toxicol Sci. 2021 Apr 12;180(2):356-368. doi: 10.1093/toxsci/kfaa194. PMID: 33483756; PMCID: PMC7928616.
Queyriaux B, Carlioz R, Perrier E, Micaelli P, Gressard A, Deroche J, Leduc PA, Quiniou G, Burlaton JP. Les effets cardiovasculaires liés à l'utilisation de la chloroquine [Cardiovascular effects linked to the use of chloroquine]. Ann Cardiol Angeiol (Paris). 2001 Sep;50(5):285-92. French. doi: 10.1016/s0003-3928(01)00029-4. PMID: 12555589.
Veinot JP, Mai KT, Zarychanski R. Chloroquine related cardiac toxicity. J Rheumatol. 1998 Jun;25(6):1221-5. PMID: 9632091.
El aichaoui S, Amine B, Saoud B, Guedira N, Allali F, Hajjaj-Hassouni N. Bloc auriculoventriculaire complet au cours d'un traitement par chloroquine [Complete auriculoventricular block during chloroquine treatment]. Rev Med Interne. 2007 Feb;28(2):134-6. French. doi: 10.1016/j.revmed.2006.10.331. Epub 2006 Nov 13. PMID: 17150283.
Cohen IV, Makunts T, Moumedjian T, Issa MA, Abagyan R. Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports. Sci Rep. 2020 Nov 5;10(1):19199. doi: 10.1038/s41598-020-76258-0. PMID: 33154498; PMCID: PMC7644696.
Guedira N, Hajjaj-Hassouni N, Srairi JE, el Hassani S, Fellat R, Benomar M. Third-degree atrioventricular block in a patient under chloroquine therapy. Rev Rhum Engl Ed. 1998 Jan;65(1):58-62. PMID: 9523387.
Teixeira RA, Martinelli Filho M, Benvenuti LA, Costa R, Pedrosa AA, Nishióka SA. Cardiac damage from chronic use of chloroquine: a case report and review of the literature. Arq Bras Cardiol. 2002 Jul;79(1):85-8. doi: 10.1590/s0066-782x2002001000009. PMID: 12163948.
Mubagwa K. Cardiac effects and toxicity of chloroquine: a short update. Int J Antimicrob Agents. 2020 Aug;56(2):106057. doi: 10.1016/j.ijantimicag.2020.106057. Epub 2020 Jun 19. PMID: 32565195; PMCID: PMC7303034.
Reuss-Borst M, Berner B, Wulf G, Müller GA. Complete heart block as a rare complication of treatment with chloroquine. J Rheumatol. 1999 Jun;26(6):1394-5. PMID: 10381062.
Chatre C, Roubille F, Vernhet H, Jorgensen C, Pers YM. Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature. Drug Saf. 2018 Oct;41(10):919-931. doi: 10.1007/s40264-018-0689-4. PMID: 29858838.
Vereckei A, Fazakas A, Baló T, Fekete B, Molnár MJ, Karádi I. Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement. Immunopharmacol Immunotoxicol. 2013 Apr;35(2):304-6. doi: 10.3109/08923973.2013.766801. Epub 2013 Feb 15. PMID: 23409733.
Tönnesmann E, Kandolf R, Lewalter T. Chloroquine cardiomyopathy - a review of the literature. Immunopharmacol Immunotoxicol. 2013 Jun;35(3):434-42. doi: 10.3109/08923973.2013.780078. Epub 2013 May 1. PMID: 23635029.
Baguet JP, Tremel F, Fabre M. Chloroquine cardiomyopathy with conduction disorders. Heart. 1999 Feb;81(2):221-3. doi: 10.1136/hrt.81.2.221. PMID: 9922366; PMCID: PMC1728937.
LOFTUS LR. PERIPHERAL NEUROPATHY FOLLOWING CHLOROQUINE THERAPY. Can Med Assoc J. 1963 Nov 2;89(18):917-20. PMID: 14052974; PMCID: PMC1921850.
Becerra-Cuñat JL, Coll-Cantí J, Gelpí-Mantius E, Ferrer-Avellí X, Lozano-Sánchez M, Millán-Torné M, Ojanguren I, Ariza A, Olivé A. Miopatía y neuropatía inducida por cloroquina: tetraparesia progresiva con arreflexia que simula una polirradiculoneuropatía. A propósito de dos casos [Chloroquine-induced myopathy and neuropathy: progressive tetraparesis with areflexia that simulates a polyradiculoneuropathy. Two case reports]. Rev Neurol. 2003 Mar 16-31;36(6):523-6. Spanish. PMID: 12652413.
Estes ML, Ewing-Wilson D, Chou SM, Mitsumoto H, Hanson M, Shirey E, Ratliff NB. Chloroquine neuromyotoxicity. Clinical and pathologic perspective. Am J Med. 1987 Mar;82(3):447-55. doi: 10.1016/0002-9343(87)90444-x. PMID: 3826099.
Biguetti CC, Junior JFS, Fiedler MW, Marrelli MT, Brotto M. The toxic effects of chloroquine and hydroxychloroquine on skeletal muscle: a systematic review and meta-analysis. Sci Rep. 2021 Mar 23;11(1):6589. doi: 10.1038/s41598-021-86079-4. PMID: 33758324; PMCID: PMC7988151.
Nucci A, Queiroz LS, Samara AM. Chloroquine neuromyopathy. Clin Neuropathol. 1996 Sep-Oct;15(5):256-8. PMID: 8879864.
Albay D, Adler SG, Philipose J, Calescibetta CC, Romansky SG, Cohen AH. Chloroquine-induced lipidosis mimicking Fabry disease. Mod Pathol. 2005 May;18(5):733-8. doi: 10.1038/modpathol.3800344. PMID: 15605079.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Sylwia Zdun, Klaudia Walczak, Weronika Gaweł, Zuzanna Wesołowska, Przemysław Jędruszczak, Natalia Grzywna, Sylwia Nemeczek, Konrad Merkisz, Jakub Grzybowski, Patrycja Walczak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 482
Number of citations: 0